During the past year, it has become apparent that members of the fibroblast growth factor (FGF) family of ligands and receptors are both required and essential for normal skeletal growth. Recent observations show that a number of inherited disorders of skeletal growth are due to point mutations in FGF receptors. It is also known that members of the FGF superfamily are expressed by bone cells, store in the bone matrix and stimulate bone formation in vivo. However, there are many important unanswered questions which need to be addressed, particularly with respect to the effects of this growth factor family on normal bone cell proliferation and differentiation, which ligands and receptors are responsible for the effects of the FGF's in normal skeletal development, and the potential for this information to be used therapeutically to stimulate bone formation. We believe the tools are now available to answer some of these important questions. We propose the following set of objective. 1. Identification of the FGF receptors and ligands which are expressed in normal bone cells during normal bone cell differentiation in vitro and in vivo. 2. Evaluation of mutant forms of FGF's for effects on bone in vitro and in vivo. Our knowledge of the regulatory mechanisms for normal bone formation is not well developed. The recent observations in these inherited disorders of skeletal development point to an important role of the FGF family of ligands receptors. The experiments we propose are designed to increase our knowledge of their precise effects on bones cells during normal bone formation and test their potential as therapies for common bone diseases.

Agency
National Institute of Health (NIH)
Institute
National Institute of Arthritis and Musculoskeletal and Skin Diseases (NIAMS)
Type
Research Project (R01)
Project #
5R01AR028149-19
Application #
2899833
Study Section
Special Emphasis Panel (ZRG4-OBM-2 (01))
Program Officer
Sharrock, William J
Project Start
1980-07-01
Project End
2001-03-31
Budget Start
1999-04-01
Budget End
2000-03-31
Support Year
19
Fiscal Year
1999
Total Cost
Indirect Cost
Name
University of Texas Health Science Center San Antonio
Department
Internal Medicine/Medicine
Type
Schools of Medicine
DUNS #
800772162
City
San Antonio
State
TX
Country
United States
Zip Code
78229
Hiraga, Toru; Myoui, Akira; Hashimoto, Nobuyuki et al. (2012) Bone-derived IGF mediates crosstalk between bone and breast cancer cells in bony metastases. Cancer Res 72:4238-49
Yoneda, Toshiyuki; Hashimoto, Nobuyuki; Hiraga, Toru (2004) Bisphosphonate actions on bone and visceral metastases. Cancer Treat Res 118:213-29
Hiraga, Toru; Williams, Paul J; Ueda, Akimi et al. (2004) Zoledronic acid inhibits visceral metastases in the 4T1/luc mouse breast cancer model. Clin Cancer Res 10:4559-67
Mori, Yoshihisa; Shimizu, Nobuaki; Dallas, Mark et al. (2004) Anti-alpha4 integrin antibody suppresses the development of multiple myeloma and associated osteoclastic osteolysis. Blood 104:2149-54
Myoui, Akira; Nishimura, Riko; Williams, Paul J et al. (2003) C-SRC tyrosine kinase activity is associated with tumor colonization in bone and lung in an animal model of human breast cancer metastasis. Cancer Res 63:5028-33
Nishimura, Riko; Hata, Kenji; Ikeda, Fumiyo et al. (2003) The role of Smads in BMP signaling. Front Biosci 8:s275-84
Hata, Kenji; Nishimura, Riko; Ikeda, Fumiyo et al. (2003) Differential roles of Smad1 and p38 kinase in regulation of peroxisome proliferator-activating receptor gamma during bone morphogenetic protein 2-induced adipogenesis. Mol Biol Cell 14:545-55
Michigami, Toshimi; Hiraga, Toru; Williams, Paul J et al. (2002) The effect of the bisphosphonate ibandronate on breast cancer metastasis to visceral organs. Breast Cancer Res Treat 75:249-58
Nishimura, R; Hata, K; Harris, S E et al. (2002) Core-binding factor alpha 1 (Cbfa1) induces osteoblastic differentiation of C2C12 cells without interactions with Smad1 and Smad5. Bone 31:303-12
Yi, Bing; Williams, Paul J; Niewolna, Marie et al. (2002) Tumor-derived platelet-derived growth factor-BB plays a critical role in osteosclerotic bone metastasis in an animal model of human breast cancer. Cancer Res 62:917-23

Showing the most recent 10 out of 64 publications